Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$146M Sell
404,031
-29,273
-7% -$10M 0.29% 60
2026
Q1
$152M Buy
433,304
+141,330
+48% +$50.4M 0.37% 44
2025
Q4
$95.6M Sell
291,974
-66,197
-18% -$21M 0.22% 79
2025
Q3
$101M Sell
358,171
-126,665
-26% -$36.7M 0.25% 65
2025
Q2
$135M Buy
484,836
+47,957
+11% +$13.6M 0.34% 54
2025
Q1
$136M Buy
436,879
+139,634
+47% +$41.2M 0.42% 40
2024
Q4
$77.5M Sell
297,245
-95,338
-24% -$28.3M 0.23% 72
2024
Q3
$126M Buy
392,583
+317
+0.1% +$104K 0.42% 38
2024
Q2
$123M Sell
392,266
-52,048
-12% -$15.3M 0.45% 34
2024
Q1
$126M Buy
+444,314
New +$130M 0.4% 45

Other funds holding AMGN

Danske Bank's AMGN Position: Q2 2026 in Review

Danske Bank reduced its Amgen (AMGN) stake by 6.8% in Q2 2026, selling an estimated $10M and leaving 404,031 shares worth $146M. The position accounts for 0.29% of the portfolio, ranked #60.

Danske Bank first reported a position in AMGN in Q1 2024 and has held it in 10 quarters since. The position peaked at $152M in Q1 2026. 3,137 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Danske Bank held 404,031 shares of Amgen worth $146M as of Q2 2026.
  • Danske Bank sold 29,273 Amgen shares in Q2 2026, an estimated $10M.
  • Amgen made up 0.29% of Danske Bank's portfolio in Q2 2026, its #60 holding.
  • Danske Bank first reported a position in Amgen in Q1 2024 and has held it in 10 quarters since.
  • Danske Bank's Amgen position peaked at $152M in Q1 2026.
  • 3,137 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Danske Bank's 13F filing for Q2 2026, filed 10 Aug 2026.